228 related articles for article (PubMed ID: 34035281)
1. mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease.
Cao J; Choi M; Guadagnin E; Soty M; Silva M; Verzieux V; Weisser E; Markel A; Zhuo J; Liang S; Yin L; Frassetto A; Graham AR; Burke K; Ketova T; Mihai C; Zalinger Z; Levy B; Besin G; Wolfrom M; Tran B; Tunkey C; Owen E; Sarkis J; Dousis A; Presnyak V; Pepin C; Zheng W; Ci L; Hard M; Miracco E; Rice L; Nguyen V; Zimmer M; Rajarajacholan U; Finn PF; Mithieux G; Rajas F; Martini PGV; Giangrande PH
Nat Commun; 2021 May; 12(1):3090. PubMed ID: 34035281
[TBL] [Abstract][Full Text] [Related]
2. G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a.
Roseman DS; Khan T; Rajas F; Jun LS; Asrani KH; Isaacs C; Farelli JD; Subramanian RR
Mol Ther; 2018 Mar; 26(3):814-821. PubMed ID: 29428299
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage.
Cho JH; Lee YM; Starost MF; Mansfield BC; Chou JY
J Inherit Metab Dis; 2019 May; 42(3):459-469. PubMed ID: 30637773
[TBL] [Abstract][Full Text] [Related]
4. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.
Lee YM; Jun HS; Pan CJ; Lin SR; Wilson LH; Mansfield BC; Chou JY
Hepatology; 2012 Nov; 56(5):1719-29. PubMed ID: 22422504
[TBL] [Abstract][Full Text] [Related]
5. Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice.
Clar J; Mutel E; Gri B; Creneguy A; Stefanutti A; Gaillard S; Ferry N; Beuf O; Mithieux G; Nguyen TH; Rajas F
Hum Mol Genet; 2015 Apr; 24(8):2287-96. PubMed ID: 25561689
[TBL] [Abstract][Full Text] [Related]
6. Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors.
Kim GY; Lee YM; Kwon JH; Cho JH; Pan CJ; Starost MF; Mansfield BC; Chou JY
Mol Genet Metab; 2017 Mar; 120(3):229-234. PubMed ID: 28096054
[TBL] [Abstract][Full Text] [Related]
7. Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas.
Mutel E; Abdul-Wahed A; Ramamonjisoa N; Stefanutti A; Houberdon I; Cavassila S; Pilleul F; Beuf O; Gautier-Stein A; Penhoat A; Mithieux G; Rajas F
J Hepatol; 2011 Mar; 54(3):529-37. PubMed ID: 21109326
[TBL] [Abstract][Full Text] [Related]
8. A splice-switching oligonucleotide treatment ameliorates glycogen storage disease type 1a in mice with G6PC c.648G>T.
Ito K; Tajima G; Kamisato C; Tsumura M; Iwamoto M; Sekiguchi Y; Numata Y; Watanabe K; Yabe Y; Kanki S; Fujieda Y; Goto K; Sogawa Y; Oitate M; Nagase H; Tsuji S; Nishizawa T; Kakuta M; Masuda T; Onishi Y; Koizumi M; Nakamura H; Okada S; Matsuo M; Takaishi K
J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 37788110
[TBL] [Abstract][Full Text] [Related]
9. Emerging roles of autophagy in hepatic tumorigenesis and therapeutic strategies in glycogen storage disease type Ia: A review.
Cho JH; Weinstein DA; Lee YM
J Inherit Metab Dis; 2021 Jan; 44(1):118-128. PubMed ID: 32474930
[TBL] [Abstract][Full Text] [Related]
10. Studies on glycogen storage disease type 1a animal models: a brief perspective.
Petrova IO; Smirnikhina SA
Transgenic Res; 2022 Dec; 31(6):593-606. PubMed ID: 36006546
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of helper-dependent adenovirus vector-mediated gene therapy in murine glycogen storage disease type Ia.
Koeberl DD; Sun B; Bird A; Chen YT; Oka K; Chan L
Mol Ther; 2007 Jul; 15(7):1253-8. PubMed ID: 17505475
[TBL] [Abstract][Full Text] [Related]
12. Correction of glycogen storage disease type 1a in a mouse model by gene therapy.
Zingone A; Hiraiwa H; Pan CJ; Lin B; Chen H; Ward JM; Chou JY
J Biol Chem; 2000 Jan; 275(2):828-32. PubMed ID: 10625614
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a.
Chou JY; Zingone A; Pan CJ
Eur J Pediatr; 2002 Oct; 161 Suppl 1():S56-61. PubMed ID: 12373573
[TBL] [Abstract][Full Text] [Related]
14. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia.
Gjorgjieva M; Calderaro J; Monteillet L; Silva M; Raffin M; Brevet M; Romestaing C; Roussel D; Zucman-Rossi J; Mithieux G; Rajas F
J Hepatol; 2018 Nov; 69(5):1074-1087. PubMed ID: 30193922
[TBL] [Abstract][Full Text] [Related]
15. Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy.
Brooks ED; Landau DJ; Everitt JI; Brown TT; Grady KM; Waskowicz L; Bass CR; D'Angelo J; Asfaw YG; Williams K; Kishnani PS; Koeberl DD
J Inherit Metab Dis; 2018 Nov; 41(6):965-976. PubMed ID: 30043186
[TBL] [Abstract][Full Text] [Related]
16. Molecular, Biochemical, and Clinical Characterization of Thirteen Patients with Glycogen Storage Disease 1a in Malaysia.
Abdul Wahab SA; Yakob Y; Mohd Khalid MKN; Ali N; Leong HY; Ngu LH
Genet Res (Camb); 2022; 2022():5870092. PubMed ID: 36160031
[TBL] [Abstract][Full Text] [Related]
17. A glycogen storage disease type 1a patient with type 2 diabetes.
Sun Y; Qiang W; Wu R; Yin T; Yuan J; Yuan J; Gu Y
BMC Med Genomics; 2022 Sep; 15(1):205. PubMed ID: 36167523
[TBL] [Abstract][Full Text] [Related]
18. Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector.
Luo X; Hall G; Li S; Bird A; Lavin PJ; Winn MP; Kemper AR; Brown TT; Koeberl DD
Mol Ther; 2011 Nov; 19(11):1961-70. PubMed ID: 21730973
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy using a novel G6PC-S298C variant enhances the long-term efficacy for treating glycogen storage disease type Ia.
Zhang L; Lee C; Arnaoutova I; Anduaga J; Starost MF; Mansfield BC; Chou JY
Biochem Biophys Res Commun; 2020 Jun; 527(3):824-830. PubMed ID: 32430177
[TBL] [Abstract][Full Text] [Related]
20. Circulating exosomal microRNAs as potential biomarkers of hepatic injury and inflammation in a murine model of glycogen storage disease type 1a.
Resaz R; Cangelosi D; Morini M; Segalerba D; Mastracci L; Grillo F; Bosco MC; Bottino C; Colombo I; Eva A
Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32620541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
